Living with chronic pain is more than enduring aches — it’s a persistent challenge that affects every part of life. When pain lasts for months or years and continues despite medications, injections, physical therapy, or even surgery, it can disrupt sleep, limit mobility, impact mood, and reduce the ability to participate in work or social activities. Many patients feel trapped in a cycle of temporary relief, ongoing fatigue, and frustration when traditional therapies fall short.
For those with pain that resists conventional treatments, Spinal Cord Stimulation (SCS) offers a targeted option that works directly with the nervous system to help regulate pain signals and provide meaningful relief.
Spinal Cord Stimulation (SCS) is a therapy in which thin leads are placed near the spinal cord and connected to a small pulse generator. This system delivers precise electrical signals that help adjust how pain signals are processed before they reach the brain — reducing the perception of discomfort and improving function.
Biotronik’s Prospera™ SCS System with Embrace One™ is engineered for chronic, intractable pain of the trunk and/or limbs. The therapy typically begins with a trial phase, allowing patients and clinicians to evaluate whether SCS provides meaningful relief before proceeding with a permanent implant. During the trial, temporary or external leads are used while patients track pain levels, activity, sleep, and medication use. This ensures the therapy is individualized and effective before long‑term commitment.
Biotronik’s Prospera SCS System stands out because it combines innovative stimulation with connected, patient‑centered support:
RESONANCE™ multiphase stimulation: A proprietary stimulation paradigm designed to optimize and personalize pain relief.
Embrace One™ with HomeStream™ remote monitoring: Automatic, objective, daily transmission of device data enables proactive care and timely identification of issues without frequent clinic visits.
Full‑body MRI access: Prospera supports 1.5T and 3T full body MRI in normal operating mode with no exclusion zones, helping ensure imaging access throughout life.
Proactive support and remote programming: Remote assessment and adjustments help maintain therapy effectiveness and reduce patient and clinician burdens
Compared with traditional SCS systems, Prospera emphasizes personalized stimulation, remote support, and patient‑centered design, helping improve long‑term outcomes and convenience.
The Prospera SCS System may benefit patients who:
Experience chronic, intractable pain of the trunk or limbs that persists despite medications or prior interventions.
Are willing to participate actively in the therapy pathway (trial → permanent implant → follow‑up).
Seek improved function, better sleep, reduced medication reliance, and a more active life.
Reliable pain relief: SCS has the potential to significantly reduce chronic pain.
Enhanced function: Better mobility, improved sleep, and increased participation in daily activities.
Positive mindset: Reducing pain can help lessen worry and improve confidence and quality of life.
Medication reduction: Use of pain medications — including opioids — may decrease as pain relief improves.
Trial Phase: Temporary leads or an external stimulator test how well SCS controls pain. Patients log their pain levels, daily activity, sleep patterns, and medication use to help guide therapy decisions.
Implantation: If the trial is successful, permanent leads and the pulse generator are implanted. Patients receive education on device care, programming, MRI access, and what to expect after surgery.
Post‑Implant: Remote monitoring and follow‑up visits help optimize therapy. Patients gradually resume activities, supported by rehabilitation and lifestyle adjustments to improve overall function and quality of life. Remote data and proactive care help maintain relief over time.